preemption news from FiercePharma
News
Reps introduce anti-preemption bill
They said they would, and now they have: two Democratic Congressmen have introduced a bill that explicit allows consumers to sue medical device makers under state law. You'll recall that in February Read more...
Dems plan anti-preemption bill for devices
What the Supreme Court gives, Congress may take away. Democrats are planning to introduce legislation that would specify that FDA regulation doesn't shield device makers from state liability suits. Read more...
Did Merck settle too soon?
Yesterday, we reported that two appeals courts--in Texas and New Jersey--overturned multimillion-dollar verdicts against Merck in Vioxx cases. The Jersey court's reasoning: A state product liability Read more...
Quaid: Preemption unfair to patients
Dennis Quaid added some star power--and colorful language--to a dry legal debate yesterday. Testifying before Congress, Quaid backed people's right to sue drugmakers, saying that FDA approval Read more...
Preemption debate heats up
That little legal argument known as preemption is back in the news. You know the one: That FDA approval, being federal, supersedes any state-court lawsuits over blessed drugs and devices. Read more...
If J&J misled FDA, can patients sue?
Drug companies appear to be close to gaining a long-coveted prize: A shield against patient lawsuits. The Bush administration has been Read more...
Supremes vote 4-4 in pre-emption suit
The Supreme Court came and saw and voted but left no clarity on pre-emption behind. Because Chief Justice John Roberts sat out the case, the vote ended in a 4-4 tie, automatically affirming the lower Read more...
Supremes leaning toward pre-emption?
Yesterday court-watchers got another sneak peek at which way the Supreme Court might lean when they hear the big drug liability case next term. In hearing arguments over Michigan's law that shields Read more...
Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends